None listed
Conditions
Interventions
Examination on screening visit - Use the test sample on the whole body for two weeks - Examination such as observation and measurement on after two weeks visit - Use the test sample on the whole body
Sponsors
Inforward, inc EBISU skin research center
CliniPro Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects who is satisfying all of the following criteria. 1)Healthy babies (male and female) aged 28 days-old to 11 months-old. 2)Subjects' protectors (parents or guardians) who are able to show their willingness of participating to the test, and to sign the consent form after understanding details of the test. 3)Subjects and their protectors who can manage in persion visit for all required visits.
Exclusion criteria
Exclusion criteria: 1)Premature babies. 2)Subjects with birth weight <2,500g. 3)Subjects who have severe eczema infantile. 4)Subjects who have skin symptom such as atopic dermatitis. 5)Subjects who have trauma on the part that uses the test sample. 6)Subjects who have possibility to be exposed to many quantity of sunlight during implementing the test. 7)Subjects who are participating in clinical tests and use tests that apply cosmetic, quasi-drugs and others. 8)Subjects who have allergic symptoms against external medicine, cosmetic, quasi-drugs and others in the past. 9)Subjects who have medical history of serious liver dysfuction, kidney dysfuction and myocardial infarction. 10)Subject who are visiting the hospital regulary for receiving the medical treatment due to the diseases. 11)Subjects who have their family they are working at cosmetic companies and pharmaceutical companies. 12)Others, subjects who have been determined that he/she is ineligible by investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes over time of the systemic skin, between screening visit and after four weeks visit, observed by the Investigators, such as dryness or scale, desquamation, erythema, papules, scratch mark, feeling of stimulation and pruritus. | — |
Secondary
| Measure | Time frame |
|---|---|
| * Changes over time of the systemic skin, between screening visit and after two weeks visit, observed by the Investigators, such as dryness or scale, desquamation, erythema, papules, scratch mark, feeling of stimulation and pruritus. * Changes over time of the quantity of stratum corneum water content and transepidermal water loss between screening visit, after two weeks visit and after four weeks visit. | — |
Countries
Japan
Contacts
Public ContactKanako Sakurai
Inforward, inc EBISU skin research center
Outcome results
None listed